Home Supplements How We Rate Blog
Tocopherol

Vitamin E

Research reviewed: Up until 03/2026

Vitamin E (Tocopherol) is a dietary supplement with 13 published peer-reviewed studies involving 3,850 participants, researched for Antioxidant Protection, Cardiovascular Health, Immune Support.

13
Studies
3,850
Participants
1996–2023
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Very Strong Evidence

Antioxidant Protection

Strong
4 studies 3 of 4 positive 101 participants

Cardiovascular Health

Moderate
4 studies 2 of 4 positive 2,455 participants

Immune Support

Strong
5 studies 3 of 5 positive 992 participants

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

11/13
Randomised
11/13
Double-Blind
11/13
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2005)
30
Study 2 (2001)
50
Study 3 (2003)
21
Study 4 (2013)
0
Study 5 (1996)
2,002
Study 6 (2002)
353
Study 7 (2010)
60
Study 8 (1999)
40

Research Timeline

When the studies were published

1
1996
1
1997
1
1998
1
1999
1
2001
1
2002
1
2003
1
2004
1
2005
2
2010
1
2013
1
2023

All Studies

Detailed breakdown of each trial. Click to expand.

Antioxidant Protection

1

To evaluate effects of vitamin E supplementation on oxidative stress markers in type 2 diabetes

2005 30 participants 3 months 800 IU/day alpha-tocopherol
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate effects of vitamin E supplementation on oxidative stress markers in type 2 diabetes

Dose

800 IU/day alpha-tocopherol

Participants

30 T2DM adults

Duration

3 months

Results

Vitamin E significantly reduced oxidative stress markers including MDA and 8-isoprostane vs placebo.

How They Measured It

MDA, antioxidant enzymes, 8-isoprostane

Read full study
2

To assess vitamin E supplementation on LDL oxidation in healthy individuals

2001 50 participants 8 weeks 400 IU/day
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To assess vitamin E supplementation on LDL oxidation in healthy individuals

Dose

400 IU/day

Participants

50 healthy adults

Duration

8 weeks

Results

Vitamin E significantly reduced LDL oxidation susceptibility vs placebo (lag time increased 26%).

How They Measured It

LDL oxidation susceptibility, plasma tocopherol

Read full study
3

To evaluate the effect of vitamin E supplementation on exercise-induced oxidative stress

2003 21 participants 24 weeks 800 mg alpha-tocopherol
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate the effect of vitamin E supplementation on exercise-induced oxidative stress

Dose

800 mg alpha-tocopherol

Participants

21 trained cyclists

Duration

24 weeks

Results

Vitamin E significantly reduced exercise-induced lipid peroxidation and improved antioxidant defence.

How They Measured It

Lipid peroxidation, antioxidant capacity

Read full study
4

To evaluate the effect of antioxidant vitamin supplementation including vitamin E on cardiovascular outcomes

2013 ? participants Various Various
Human Study Mixed

Study Type

Systematic review and meta-analysis

Purpose

To evaluate the effect of antioxidant vitamin supplementation including vitamin E on cardiovascular outcomes

Dose

Various

Participants

Multiple large RCTs pooled

Duration

Various

Results

Vitamin E supplementation had mixed effects; reduced LDL oxidation consistently but inconsistent effects on cardiovascular events.

How They Measured It

Cardiovascular events, mortality, meta-analysis

Read full study

Cardiovascular Health

5

To test whether high-dose alpha-tocopherol reduces risk of myocardial infarction in established ischaemic heart disease

1996 2002 participants ~1.4 years 400-800 IU/day alpha-tocopherol
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled (CHAOS Trial)

Purpose

To test whether high-dose alpha-tocopherol reduces risk of myocardial infarction in established ischaemic heart disease

Dose

400-800 IU/day alpha-tocopherol

Participants

2002 adults with established ischaemic heart disease

Duration

~1.4 years

Results

Significant reduction in non-fatal MI risk (77% reduction, p=0.005); no significant effect on cardiovascular death.

How They Measured It

Myocardial infarction, cardiovascular death

Read full study
6

To evaluate alpha-tocopherol supplementation on atherosclerosis progression in healthy individuals

2002 353 participants 3 years 400 IU/day alpha-tocopherol
Human Study RCT Double-Blind Placebo Mixed

Study Type

Randomised, double-blind, placebo-controlled (VEAPS Trial)

Purpose

To evaluate alpha-tocopherol supplementation on atherosclerosis progression in healthy individuals

Dose

400 IU/day alpha-tocopherol

Participants

353 healthy adults at risk for CVD

Duration

3 years

Results

Alpha-tocopherol reduced LDL oxidation significantly but did not significantly reduce carotid atherosclerosis progression.

How They Measured It

Carotid intima-media thickness (CIMT), LDL oxidation

Read full study
7

To evaluate vitamin E supplementation on arterial stiffness in metabolic syndrome patients

2010 60 participants 12 weeks 800 IU/day mixed tocopherols
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate vitamin E supplementation on arterial stiffness in metabolic syndrome patients

Dose

800 IU/day mixed tocopherols

Participants

60 metabolic syndrome patients

Duration

12 weeks

Results

Vitamin E significantly improved endothelial function and reduced arterial stiffness markers vs placebo.

How They Measured It

Pulse wave velocity, augmentation index, endothelial function

Read full study
8

To assess vitamin E effects on platelet aggregation and thrombosis risk

1999 40 participants 8 weeks 400 IU/day vitamin E
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To assess vitamin E effects on platelet aggregation and thrombosis risk

Dose

400 IU/day vitamin E

Participants

40 adults with diabetes

Duration

8 weeks

Results

Vitamin E significantly reduced platelet aggregation and thromboxane B2 levels vs placebo.

How They Measured It

Platelet aggregation, thromboxane B2

Read full study

Immune Support

9

To evaluate high-dose vitamin E supplementation on immune function in elderly adults

1997 88 participants 235 days 200 mg/day all-rac alpha-tocopherol
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate high-dose vitamin E supplementation on immune function in elderly adults

Dose

200 mg/day all-rac alpha-tocopherol

Participants

88 healthy elderly adults

Duration

235 days

Results

Vitamin E at 200 mg significantly improved delayed-type hypersensitivity and antibody titres in the elderly.

How They Measured It

DTH skin test, antibody response, T-cell function

Read full study
10

To assess the effect of vitamin E supplementation on common cold duration and severity

2004 617 participants 12 months 400 IU/day vitamin E
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To assess the effect of vitamin E supplementation on common cold duration and severity

Dose

400 IU/day vitamin E

Participants

617 nursing home elderly

Duration

12 months

Results

Vitamin E did not reduce risk of common cold but significantly reduced severity and duration.

How They Measured It

Cold duration, symptom severity, immune biomarkers

Read full study
11

To evaluate vitamin E supplementation on non-alcoholic fatty liver disease (NAFLD)

2010 247 participants 96 weeks 800 IU/day vitamin E
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate vitamin E supplementation on non-alcoholic fatty liver disease (NAFLD)

Dose

800 IU/day vitamin E

Participants

247 non-diabetic NAFLD adults

Duration

96 weeks

Results

Vitamin E significantly improved histological NAFLD scores and reduced liver enzymes vs placebo (p=0.001).

How They Measured It

ALT, AST, liver biopsy histological scores

Read full study
12

To evaluate vitamin E and skin photoprotection in adults

1998 40 participants 3 months 400 IU/day vitamin E + 2 g vitamin C
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate vitamin E and skin photoprotection in adults

Dose

400 IU/day vitamin E + 2 g vitamin C

Participants

40 healthy adults

Duration

3 months

Results

Combined vitamin E and C significantly reduced UV-induced erythema and improved photoprotection.

How They Measured It

Erythema index, skin photoprotection, UV damage

Read full study
13

To evaluate vitamin E supplementation and cardiovascular health comprehensively

2023 ? participants Various Various
Human Study Mixed

Study Type

Systematic review and meta-analysis

Purpose

To evaluate vitamin E supplementation and cardiovascular health comprehensively

Dose

Various

Participants

Multiple large trials

Duration

Various

Results

Vitamin E consistently reduces oxidative stress and has positive immune effects; cardiovascular effects context-dependent.

How They Measured It

Systematic review of cardiovascular outcomes, immune function, antioxidant effects

Read full study

Frequently Asked Questions

Common questions about Vitamin E research

What does the research say about Vitamin E?

There are currently 13 peer-reviewed studies on Vitamin E (Tocopherol), involving 3,850 total participants. Research covers Antioxidant protection, Cardiovascular health, Immune support. The overall evidence strength is rated as Very Strong.

How strong is the evidence for Vitamin E?

The evidence is currently rated as "Very Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (13 human studies), and reported outcomes.

What health goals has Vitamin E been studied for?

Vitamin E has been researched for: Antioxidant protection, Cardiovascular health, Immune support. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Vitamin E based on human trials?

Yes, 13 out of 13 studies are human trials. Human trials carry more weight in our evidence scoring system.